247 related articles for article (PubMed ID: 8439222)
1. Oral anticoagulant therapy--50 years later.
Ansell JE
Arch Intern Med; 1993 Mar; 153(5):586-96. PubMed ID: 8439222
[TBL] [Abstract][Full Text] [Related]
2. Oral anticoagulant therapy: practical considerations.
Ansell JE; Holden A; Nozzolillo E
Nurse Pract Forum; 1992 Jun; 3(2):105-13. PubMed ID: 1392666
[TBL] [Abstract][Full Text] [Related]
3. [Present and future of oral anticoagulants].
Meschengieser SS; Casais P; Sánchez Luceros A; Lazzari MA
Medicina (B Aires); 2000; 60(1):139-42. PubMed ID: 10835711
[TBL] [Abstract][Full Text] [Related]
4. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
[TBL] [Abstract][Full Text] [Related]
5. [-Anticoagulant drugs-].
Gulba DC
Herz; 1996 Feb; 21(1):12-27. PubMed ID: 8647576
[TBL] [Abstract][Full Text] [Related]
6. Patient education and oral anticoagulant therapy.
Barcellona D; Contu P; Marongiu F
Haematologica; 2002 Oct; 87(10):1081-6. PubMed ID: 12368164
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy.
Anderson DR; Harrison L; Hirsh J
Arch Intern Med; 1993 Jun; 153(12):1441-7. PubMed ID: 8512435
[TBL] [Abstract][Full Text] [Related]
8. [Anticoagulant prophylaxis: from clinical trials to clinical practice].
Scardi S; Mazzone C
G Ital Cardiol; 1998 Feb; 28(2):178-86. PubMed ID: 9534059
[TBL] [Abstract][Full Text] [Related]
9. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123
[TBL] [Abstract][Full Text] [Related]
10. Outpatient oral anticoagulant management--an audit of 82 patients.
Kakkar N; Kaur R; John M
J Assoc Physicians India; 2005 Oct; 53():847-52. PubMed ID: 16459526
[TBL] [Abstract][Full Text] [Related]
11. [A retrospective survey on practice of oral anticoagulant therapy in patients with cardiovascular diseases].
Katona A; Márk L
Orv Hetil; 2004 Aug; 145(32):1643-7. PubMed ID: 15384862
[TBL] [Abstract][Full Text] [Related]
12. [Oral anticoagulants in cardiac patients undergoing elective surgical procedures: what attitude to adopt?].
Yerly P; Schapira M; Vogt P
Rev Med Suisse; 2005 May; 1(21):1412-4, 1416-7. PubMed ID: 15997979
[TBL] [Abstract][Full Text] [Related]
13. Oral anticoagulation therapy: indications, contraindications, and complications.
Donhou GE
Nurse Pract Forum; 1992 Jun; 3(2):86-94. PubMed ID: 1392676
[TBL] [Abstract][Full Text] [Related]
14. Management of oral anticoagulant treatment in patients with venous thromboembolism.
Pengo V
Semin Thromb Hemost; 2006 Nov; 32(8):781-6. PubMed ID: 17171590
[TBL] [Abstract][Full Text] [Related]
15. The efficacy and safety of perioperative low molecular weight heparin substitution in patients on chronic oral anticoagulant therapy undergoing transurethral prostatectomy for bladder outlet obstruction.
Dotan ZA; Mor Y; Leibovitch I; Varon D; Golomb J; Duvdevani M; Ramon J
J Urol; 2002 Aug; 168(2):610-3; discussion 614. PubMed ID: 12131319
[TBL] [Abstract][Full Text] [Related]
16. Ximelagatran: a new oral anticoagulant.
Hrebickova L; Nawarskas JJ; Anderson JR
Heart Dis; 2003; 5(6):397-408. PubMed ID: 14633322
[TBL] [Abstract][Full Text] [Related]
17. Outpatient management of oral vitamin K antagonist therapy: defining and measuring high-quality management.
Phillips KW; Ansell J
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):57-70. PubMed ID: 18095907
[TBL] [Abstract][Full Text] [Related]
18. Bleeding risk of combined oral anticoagulant and antiplatelet therapy in cardiovascular disease.
Verheugt FW
J Cardiovasc Risk; 1996 Apr; 3(2):229-32. PubMed ID: 8836868
[TBL] [Abstract][Full Text] [Related]
19. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetic aspects of overdosage and intoxication with oral anticoagulant drugs (author's transl)].
Jähnchen E; Meinertz T
Arzneimittelforschung; 1977; 27(96):1849-56. PubMed ID: 303522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
